Logo

Biolytix to Offer Affymetrix UK's GeneChip Arrays to European Clients

Nov 30, 2007
NEW YORK (GenomeWeb News) – Swiss analytical services company Biolytix has bought an Affymetrix GeneChip instrument and has signed a service provider agreement with Affymetrix UK, Biolytix said today.
 
The company plans to use the GeneChip platform to offer exon and tiling arrays and SNP genotyping and gene-mapping arrays that could be used in transcriptome mapping, gene regulation, genome-wide SNP mapping, and re-sequencing.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.